Where can I buy TAGRISSO 40mg?

Pharmacy Remedy supplies genuine AstraZeneca TAGRISSO 40mg internationally. Contact us via WhatsApp at +44 7429 917553 for availability and wholesale pricing.

When is TAGRISSO 40mg used instead of 80mg?

TAGRISSO 40mg is the recommended dose reduction for patients who cannot tolerate the standard 80mg dose due to adverse events such as QTc prolongation, interstitial lung disease, or severe diarrhea. It allows continued treatment while managing side effects.

Is TAGRISSO 40mg still effective?

Yes, TAGRISSO 40mg remains clinically effective for EGFR-mutated NSCLC. While the standard dose is 80mg, the 40mg dose maintains therapeutic drug levels and continues to provide disease control in patients requiring dose reduction.

What are the side effects of TAGRISSO?

Common side effects include diarrhea, rash, dry skin, nail changes, and fatigue. At the 40mg dose, these side effects may be less severe or more manageable than at 80mg while maintaining efficacy.

TAGRISSO

40mg

Oncology Medications

TAGRISSO40mg

Name: TAGRISSO 40mg
Brand: AstraZeneca
SKU: tagrisso-40mg
Availability: InStock

TAGRISSO (osimertinib) 40mg is a third-generation EGFR tyrosine kinase inhibitor for EGFR-mutated non-small cell lung cancer, available as a lower dose option.

Generic Name:Osimertinib

Manufacturer:AstraZeneca

Key Benefits

Dose reduction option for optimal tolerability
Maintains EGFR mutation-targeting efficacy
Continues CNS penetration for brain metastases
Once-daily oral convenience
Authentic AstraZeneca product

Contact Us for Pricing

Get competitive wholesale pricing for TAGRISSO 40mg. Our team is available 24/7.

Direct line: +44 7429 917553

Licensed Supplier

Authorized pharmaceutical distributor

100% Original

Guaranteed authentic products

Worldwide Delivery

International shipping available

24/7 Support

WhatsApp support anytime

How TAGRISSO Works

TAGRISSO 40mg works identically to the 80mg formulation—by irreversibly and selectively inhibiting EGFR with sensitizing mutations (exon 19 deletions, L858R) and the T790M resistance mutation that commonly develops during treatment with first-generation EGFR TKIs.

By blocking mutant EGFR signaling, TAGRISSO shuts down the RAS-RAF-MEK-ERK and PI3K-AKT pathways that drive cancer cell survival, proliferation, and metastasis. The drug's selectivity for mutant EGFR over wild-type EGFR contributes to its favorable toxicity profile.

Even at the 40mg dose, TAGRISSO achieves effective CNS penetration, continuing to provide control of brain metastases—a critical consideration in EGFR-mutated lung cancer where CNS involvement is common.

About TAGRISSO 40mg

TAGRISSO (osimertinib) 40mg by AstraZeneca represents the dose-reduced formulation of this groundbreaking third-generation EGFR tyrosine kinase inhibitor. This lower dose option is essential for patients who require dose modification due to adverse events while maintaining effective treatment of EGFR-mutated non-small cell lung cancer. The 40mg formulation allows oncologists to optimize treatment by balancing efficacy and tolerability. Patients who experience dose-limiting toxicities on the standard 80mg dose can continue benefiting from TAGRISSO's superior efficacy at this reduced dose level. TAGRISSO 40mg maintains the same mechanism of action—selectively targeting EGFR-sensitizing mutations and T790M resistance mutations while sparing wild-type EGFR. This selectivity translates to improved tolerability compared to earlier-generation EGFR inhibitors. Pharmacy Remedy provides authentic AstraZeneca TAGRISSO 40mg tablets for healthcare facilities and distributors worldwide, ensuring patients have access to both dose levels for optimal personalized treatment.